Description
Anastrocyl® is an oral tablet preparation containing anastrozole, a non-steroidal triazole-derived small-molecule compound classified as an aromatase inhibitor. Unlike steroidal esters, peptide-based injectables or protein compounds, anastrozole is presented as the active compound itself in a solid oral dosage form.
The tablet format is suited to a low-molecular-weight compound intended for gastrointestinal absorption after oral administration. In this form, the active substance is provided as a measured unit dose, without oil-depot release, ester hydrolysis, peptide solubility requirements or crystalline suspension behaviour.
Further details on composition, method of use, precautions, possible side effects, contraindications and storage are provided in the package leaflet.